The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202
Open accessAbstract
BACKGROUND: Long-term effects of abacavir (ABC)-lamivudine (3TC), compared with tenofovir (TDF)-emtricitabine (FTC) with efavirenz (EFV) or atazanavir plus ritonavir (ATV/r), on bone mineral density (BMD) have not been analyzed. METHODS: A5224s was a substudy of A5202, in which HIV-infected treatment-naive participants were randomized and blinded to receive ABC-3TC or TDF-FTC with open-label EFV or ATV/r. Primary bone end points included Dual-emission X-ray absorbtiometry (DXA)-measured percent changes in spine and hip BMD at week 96. Primary analyses were intent-to-treat. Statistical tests used the factorial design and included linear regression, 2-sample t, log-rank, and Fisher's exact tests. RESULTS: Two hundred sixty-nine persons randomized to 4 arms of ABC-3TC or TDF-FTC with EFV or ATV/r. At baseline, 85% were male, and 47% were white non-Hispanic; the median HIV-1 RNA load was 4.6 log(10) copies/mL, the median age was 38 years, the median weight was 76 kg, and the median CD4 cell count was 233 cells/μL. At week 96, the mean percentage changes from baseline in spine and hip BMD for ABC-3TC versus TDF-FTC were -1.3% and -3.3% (P = .004) and -2.6% and -4.0% (P = .024), respectively; and for EFV versus ATV/r were -1.7% and -3.1% (P = .035) and -3.1% and -3.4% (P = .61), respectively. Bone fracture was observed in 5.6% of participants. The probability of bone fractures and time to first fracture were not different across components. CONCLUSIONS: Compared with ABC-3TC, TDF-FTC-treated participants had significantly greater decreases in spine and hip BMD, whereas ATV/r led to more significant losses in spine, but not hip, BMD than EFV. Clinical Trials Registration. NCT00118898.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gallant, J. E. (2004) · JAMA · doi:10.1001/jama.292.2.191 · Cited by 1,341
Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review
Brown, T. T., & Qaqish, R. B. (2006) · AIDS · doi:10.1097/qad.0b013e32801022eb · Cited by 925
Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis
Pacifici, R. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110802 · Cited by 741
Bone Mineral Density Changes during the Menopause Transition in a Multiethnic Cohort of Women
Finkelstein, J. S., Brockwell, S. E., Mehta, V., Greendale, G. A., Sowers, M. R., Ettinger, B., Lo, J. C., Johnston, J. M., Cauley, J. A., Danielson, M. E., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1876 · Cited by 597
Triant, V. A., Brown, T. T., Lee, H., & Grinspoon, S. K. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0828 · Cited by 490
Stellbrink, H., Orkin, C., Arribas, J. R., Compston, J., Gerstoft, J., Van Wijngaerden, E., Lazzarin, A., Rizzardini, G., Sprenger, H. G., Lambert, J., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/656417 · Cited by 405
Changes in Bone Mineral Density with Age in Men and Women: A Longitudinal Study
Warming, L., Hassager, C., & Christiansen, C. (2002) · Osteoporosis International · doi:10.1007/s001980200001 · Cited by 382
Brown, T. T., McComsey, G. A., King, M. S., Qaqish, R. B., Bernstein, B. M., & da Silva, B. A. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181adce44 · Cited by 316
Self-citationAbacavir–Lamivudine versus Tenofovir–Emtricitabine for Initial HIV-1 Therapy
Sax, P. E., Tierney, C., Collier, A. C., Fischl, M. A., Mollan, K., Peeples, L., Godfrey, C., Jahed, N. C., Myers, L., Katzenstein, D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906768 · Cited by 313
Self-citationRole of cytokines in bone resorption
Manolagas, S. C. (1995) · Bone · doi:10.1016/8756-3282(95)00180-l · Cited by 312
Mondy, K., Yarasheski, K., Powderly, W. G., Whyte, M., Claxton, S., DeMarco, D., Hoffmann, M., & Tebas, P. (2003) · Clinical Infectious Diseases · doi:10.1086/367569 · Cited by 305
Self-citationDuvivier, C., Kolta, S., Assoumou, L., Ghosn, J., Rozenberg, S., Murphy, R. L., Katlama, C., & Costagliola, D. (2009) · AIDS · doi:10.1097/qad.0b013e328328f789 · Cited by 239
Reduced bone mineral density in HIV-infected patients: prevalence and associated factors
Cazanave, C., Dupon, M., Lavignolle-Aurillac, V., Barthe, N., Lawson-Ayayi, S., Mehsen, N., Mercié, P., Morlat, P., Thiébaut, R., & Dabis, F. (2008) · AIDS · doi:10.1097/qad.0b013e3282f423dd · Cited by 218
Role of cytokines in the regulation of bone resorption
Roodman, G. D. (1993) · Calcified Tissue International · doi:10.1007/bf01673412 · Cited by 178
Brown, T. T., & McComsey, G. A. (2010) · Antiviral Therapy · doi:10.3851/imp1502 · Cited by 168
Self-citationCassetti, I., Madruga, J. V. R., Suleiman, J. M. A. H., Etzel, A., Zhong, L., Cheng, A. K., Enejosa, J., & for the Study 903E Team (2007) · HIV Clinical Trials · doi:10.1310/hct0803-164 · Cited by 168
Nolan, D., Upton, R., McKinnon, E., John, M., James, I., Adler, B., Roff, G., Vasikaran, S., & Mallal, S. (2001) · AIDS · doi:10.1097/00002030-200107060-00009 · Cited by 163
Longitudinal Analysis of Bone Density in Human Immunodeficiency Virus-Infected Women
Dolan, S. E., Kanter, J. R., & Grinspoon, S. K. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0127 · Cited by 157
Noor, M. A., Flint, O. P., Maa, J., & Parker, R. A. (2006) · AIDS · doi:10.1097/01.aids.0000244200.11006.55 · Cited by 155
BMD Is Reduced in HIV-Infected Men Irrespective of Treatment
Amiel, C., Ostertag, A., Slama, L., Baudoin, C., N'Guyen, T., Lajeunie, E., Neit-Ngeilh, L., Rozenbaum, W., & De Vernejoul, M. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301246 · Cited by 150
Madeddu, G., Spanu, A., Solinas, P., Calia, G. M., Lovigu, C., Chessa, F., Mannazzu, M., Falchi, A., Mura, M. S., & Madeddu, G. (2004) · PubMed · Cited by 127
HIV‐1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNFα activation
Gibellini, D., Crignis, E. D., Ponti, C., Cimatti, L., Borderi, M., Tschon, M., Giardino, R., & Re, M. C. (2008) · Journal of Medical Virology · doi:10.1002/jmv.21266 · Cited by 113
Fakruddin, J. M., & Laurence, J. C. (2004) · Archives of Virology · doi:10.1007/s00705-004-0395-7 · Cited by 112
Jemsek, J. G., Arathoon, E., Arlotti, M., Perez, C., Sosa, N., Pokrovskiy, V., Thiry, A., Soccodato, M., Noor, M., & Giordano, M. (2005) · Clinical Infectious Diseases · doi:10.1086/498505 · Cited by 106
Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults
Collin, F., Duval, X., Moing, V. L., Piroth, L., Kaied, F. A., Massip, P., Villes, V., Chêne, G., & Raffi, F. (2009) · AIDS · doi:10.1097/qad.0b013e3283292195 · Cited by 105
Fux, C. A., Rauch, A., Simcock, M., Bucher, H. C., Hirschel, B. J., Opravil, M., Vernazza, P., Cavassini, M. L., Bernasconi, E., Elzi, L., et al. (2008) · Antiviral Therapy · doi:10.1177/135965350801300803 · Cited by 84
Regulation of Human Vitamin D3 25-Hydroxylases in Dermal Fibroblasts and Prostate Cancer LNCaP Cells
Ellfolk, M. A., Norlin, M., Gyllensten, K., et al. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.053660 · Cited by 67
Landriscina, M., Altamura, S., Roca, L., Gigante, M., Piscazzi, A., Cavalcanti, E., Costantino, E., Barone, C. A., Cignarelli, M., Gesualdo, L., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23197 · Cited by 43
Fabbriciani, G., & Socio, G. V. D. (2009) · AIDS · doi:10.1097/qad.0b013e32832bab0f · Cited by 28
Cited by
Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.
Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., Henderson, F. L., Pathak, S. R., Soud, F. A., Chillag, K. L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110711 · Cited by 1,996
Future challenges for clinical care of an ageing population infected with HIV: a modelling study
Smit, M., Brinkman, K., Geerlings, S., Smit, C., Thyagarajan, K., Sighem, A. V., de Wolf, F., & Hallett, T. B. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00056-0 · Cited by 908
Sax, P. E., Wohl, D., Yin, M. T., Post, F., DeJesus, E., Saag, M., Pozniak, A., Thompson, M., Podzamczer, D., Molina, J. M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60616-x · Cited by 601
Self-citationCurrent status and prospects of HIV treatment
Cihlar, T., & Fordyce, M. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.03.004 · Cited by 337
Bedimo, R., Maalouf, N. M., Zhang, S., Drechsler, H., & Tebas, P. (2012) · AIDS · doi:10.1097/qad.0b013e32835192ae · Cited by 324
Self-citation
Metadata
- Authors
- McComsey, G. A., Kitch, D., Daar, E. S., Tierney, C., Jahed, N. C., Tebas, P., Myers, L., Melbourne, K., Ha, B., & Sax, P. E.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-06-15
- Volume
- 203
- Issue
- 12
- Pages
- 1791-1801
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2144095981
- Cited by
- 495
- References
- 29
- FWCI
- 61.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.